Navigating the Tricky Climate of Health Tech Funding
Getting would-be investors—and the right kind of investors—to notice and care about your company requires a robust strategy.
Getting would-be investors—and the right kind of investors—to notice and care about your company requires a robust strategy.
Transcarent recently announced that it raised $126 million in Series D funding led by General Catalyst and 7wireVentures. When asked what his exit strategy is, CEO Glen Tullman said he does not want to sell Transcarent, but sees an initial public offering as an option.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Digital health companies have now raised more than $20 billion in 2021, more than any other year. While experts expect to see the dealmaking continue, they raised caution about the challenges of going public with high valuations.
The startup is developing digital therapeutics that use cognitive behavioral therapy-based programs to address cardiometabolic conditions. It began trading on Nasdaq on Friday.
The company, which provides revenue cycle management solutions for providers, is filing for the IPO less than two years after Bon Secours Mercy Health sold its majority stake in Ensemble to private equity firm Golden Gate Capital. Per the filing, the company aims to raise $100 million, but that is likely a placeholder figure.
The diagnostics company currently has an authorized at-home Covid-19 test, and plans to expand into flu tests and other diagnostics. After pricing its stock at $16 per share, it climbed to $20 on Friday.
The San Diego-based company began marketing its first product, a portable Covid-19 test, after receiving an emergency use authorization last year. Now, it’s filing the initial paperwork to go public as it scales up manufacturing.
Bright Health will use proceeds from its IPO to fund the expansion, which will bring its total number of markets to 141 from 99. The company will also expand its product portfolio in states where it already operates.
Everside Health Group, a Denver-based direct primary care startup, filed to go public. The company was formed out of a merger between three primary care groups, and primarily works with self-insured employers.
The social network for physicians recently went public in an upsized IPO that valued the company at about $4.6 billion. With many physicians already on the platform, chief strategy officer Dr. Nate Gross shared the company’s plans for future growth.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Digital therapeutics startup Pear Therapeutics struck a deal to go public through a blank-check acquisition that would value the company at $1.6B. But it still faces big challenges in selling its app-based treatments.
With plans to sell 60 million shares of common stock, Bright Health will price its IPO between $20 and $23 per share. It will trade on the New York Stock Exchange under the symbol "BHG," according to a recent SEC filing.
In Venrock’s annual survey of healthcare leaders, respondents expected most digital health startups that went public during the pandemic to see their valuations fall by the end of the year.
Doximity, the “LinkedIn for physicians,” is preparing for an IPO. In an unusual move, it’s setting aside a portion of its shares for some of its users.
Bright Health has filed preliminary paperwork for an IPO, joining its rivals in the insurance technology space in going public. Though there are few confirmed details at the moment, Bright Health is reportedly looking to raise $1 billion through the offering.